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Human embryonic stem cells (hESCs) are a valuable source of
pluripotential primary cells. To date, however, their homogeneous
cellular differentiation to specific cell types in vitro has proven
difficult. Wnt signaling has been shown to play important roles in
coordinating development, and we demonstrate that Wnt3a is
differentially expressed at critical stages of human liver develop-
ment in vivo. The essential role of Wnt3a in hepatocyte differen-
tiation from hESCs is paralleled by our in vitro model, demonstrat-
ing the importance of a physiologic approach to cellular
differentiation. Our studies provide compelling evidence that
Wnt3a signaling is important for coordinated hepatocellular func-
tion in vitro and in vivo. In addition, we demonstrate that Wnt3a
facilitates clonal plating of hESCs exhibiting functional hepatic
differentiation. These studies represent an important step toward
the use of hESC-derived hepatocytes in high-throughput metabolic
analysis of human liver function.
definitive endoderm  function  hepatocyte  drug metabolism 
high throughput
Human embryonic stem cells (hESCs) are derived from theinner cell mass of preimplantation embryos and demon-
strate pluripotency in vitro and in vivo (1, 2). Such attributes allow
hESCs to be differentiated down all germ lineages in large
numbers and offer significant advantages over their adult stem
cell counterparts, which are generally limited in their capacity to
differentiate and proliferate (3). Although these hESCs provide
a valuable source of adult differentiated cells, homogeneous
cellular differentiation to specific germ layers has proven diffi-
cult to achieve. One potential explanation for this failure is that
cells do not receive sequential developmental cues that they do
in vivo.
Wnt signaling has been shown to play an important role in
hESC self-renewal and differentiation and stimulates numerous
intracellular signal transduction cascades, including the canon-
ical pathway regulating gene expression in the nucleus and what
seems to be a network of noncanonical pathways regulating
many other aspects of cell biology [reviewed by Cadigan and Liu
(4)]. In the absence of Wnt signaling, -catenin is targeted for
degradation; however, active Wnt signaling inhibits -catenin
destruction, resulting in its nuclear translocation (5, 6). After
nuclear localization, -catenin dimerizes with the nuclear pro-
teins from the T cell factor/lymphoid enhancer factor (TCF/
LEF) family and transactivates gene expression. TCF/LEFs are
not only present in transcriptional activator complexes; they also
play a role in corepressor complex assembly (6).
The important role played by Wnt signaling during gastrula-
tion in vivo is evidenced by gene knockouts or dominant nega-
tives (7, 8). Wnt3-mediated Brachyury expression is also impor-
tant for migration of precursor cells through the anterior region
of the primitive streak (PS). The subsequent specification of the
anterior region of the PS to mesoderm or endoderm is likely to
depend on the duration and magnitude of Nodal signaling (9,
10). Following its commitment the definitive endoderm (DE)
lines the ventral region of the developing embryo and is pat-
terned by adjacent mesenchyme. Liver formation depends on 2
mesenchymal structures, the cardiac mesoderm and septum
transversum, which provide convergent instructive signals [re-
viewed by Zaret (11)].
ESCs have also been used as a cellular resource for modeling
human development in vitro. These experiments demonstrated
that the endodermal cell fate is based on the ability of a
bipotential precursor, mesendoderm, to interpret different levels
of Activin/Nodal signaling (12–16). In recent years there has
been considerable focus on generating hepatic endoderm from
ESCs. The differentiation of ESCs to hepatocytes has been
shown to occur spontaneously after embryoid body formation
(17–21) or directly using stagewise processes (19, 22, 23). Al-
though there have been improvements in efficiencies, current
strategies still yield relatively heterogeneous populations.
In this study, we demonstrate that Wnt3a is expressed at
critical stages of human liver development in vivo, highlighting its
important role in development. To study this further and model
hESC differentiation through hepatocellular precursors, we have
used Wnt3a in vitro. We demonstrate that Wnt3a elicits a rapid
and highly efficient cellular progression through the PS to
definitive and hepatic endoderm. The synergistic effect ofWnt3a
and ActivinA on hESCs produced a viable and predictable
model of human hepatic differentiation in vitro and in vivo.
Additionally, Wnt3a promotes hepatocyte-like cell (HLC) func-
tionality and facilitates clonal plating of hESCs capable of
hepatic differentiation and function. These results represent an
important step toward the use of hESC-derived HLCs in bio-
medical applications and high-throughput drug toxicity studies.
Results
Wnt3a Plays an Important Role in Developing Human Liver. During
development the liver is formed from DE. The coordination of
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cell signaling during this process is critical for normal liver
development. Wnt signaling plays an essential role in embryonic
development and cellular differentiation, and we were interested
in studying the instructive role played byWnt during human liver
development. Wnt3a expression was examined in first (T1) and
second (T2) trimester human liver sections by immunostaining.
T1 liver exhibited Wnt3a staining adjacent to developing portal
structures but was not detected in the parenchyma (Fig. 1 A and
B). However, in T2 livers the pattern of expression was both
portal and parenchymal, suggesting that Wnt3a parenchymal
expression correlated with, and possibly influenced, hepatocyte
differentiation in the developing liver (Fig. 1 C–F), suggesting a
possible role in early hepatocyte differentiation. As a control for
specificity we used a negative control throughout our immuno-
staining (Fig. 1 G and H).
hESC Transition Through the PS Is Accelerated by Wnt3a and ActivinA
Treatment.Mesoderm and endoderm are formed from a common
precursor, mesendoderm. We were interested in the role that
Wnt3a and ActivinA played throughout gastrulation and ulti-
mately DE specification. Human endoderm differentiation was
initiated using either ActivinA plus Wnt3a (AW) [supporting
information (SI) Fig. S1] or ActivinA plus sodium butyrate
(AB). hESCs were treated with AW for the first 3 days of the
experiment and developed marked changes in their cellular
morphology from day 1. AW-differentiated hESCs displayed
loose colony structure 24 h after treatment, (Fig. S1D), and by
days 2 and 3, differentiating cells had formed a confluent
monolayer with some overgrowth detected, themajority of which
was lost during subsequent phases of the cellular differentiation
(Fig. S1 E and F). In contrast, hESCs incubated with AB
displayed a much looser colony structure, not forming a con-
fluent monolayer until day 3 (Fig. S1 J–L) Of note, the areas of
overgrowth present in these cultures continued to grow through-
out subsequent phases of differentiation.
Consistent with changes in cell morphology, we observed
changes in gene expression. hESCs and differentiating cells were
immunostained for the PS marker Brachyury. Brachyury expres-
sion, absent in hESCs (Fig. S1B), was detected in 96%  0.3%
of cells treated with AW by day 1 (Fig. S1G) and decreased on
days 2 and 3, indicating cellular transition through the PS (Fig.
S1 H and I). Cells treated with AB, however, exhibited a
different pattern, with all cells expressing Brachyury for the first
3 days, suggesting slower progress through the PS (Fig. S1M–O).
The specificity of immunostaining was confirmed using an
IgG-negative control (Fig. S1C).
To fully assess cellular transition through the PS we used a
panel of lineage-specific PCR markers, which were compared
with and quoted as fold induction over hESC levels. The profile
of Brachyury gene expression in AW cells was in line with
immunostaining and confirmed more rapid cellular progression
through the PS (Fig. S2A, AW1–3) than AB cells (Fig. S2A,
AB1–3). The differential regulation of the Brachyury was par-
alleled by the expression of endodermal markers SOX17 and
HNF3. SOX17 and HNF3 levels were induced earlier in
AW-treated cells (Fig. S2B, AW1–3) than in AB-treated cells
(Fig. S2B, AB1–3). The decrease in Brachyury and faster induc-
tion of SOX17 and HNF3 suggests that cells treated with AW
transit more rapidly through the PS than cells treated with AB.
To confirm cellular commitment to DEwe assessedNODAL and
CRIPTO expression. Both treatment groups exhibited similar
patterns of expression, with entry into DE at day 3 (Fig. S2D and
E). Consistent with hESC differentiation toward the endoderm,
we observed a decrease in OCT4 levels as differentiation
proceeded in both treatment groups (Fig. S2F).
Wnt Signaling Plays an three Important Role in PS Formation and
Endoderm Specification. At least three Wnts are required for
different aspects of gastrulation. WNT3 and WNT3a are ex-
pressed in the PS of mouse and are required for mesoderm
formation (24), whereas WNT11 is expressed in the blastopore
of Xenopus and zebrafish and is thought to be involved in
controlling extension movements in gastrulation (25). WNT3,
WNT3a, and WNT11 levels were measured during PS and
endoderm formation. In line with BRACHYURY, WNT3a ex-
pression was maximal at day 1 in AW cells (Fig. 2A, AW1) and
decreased during days 2 and 3 (Fig. 2A, AW2 and AW3),
indicating that the formation of and transition through the PS
was proceeding normally. Cells differentiated with AB exhibited
a different pattern, with peak levels of WNT3a detected at day
2 (Fig. 2A, AB1–3). In both treatment groups the WNT3
induction profile was similar throughout the PS transition,
indicating that WNT3 was important for PS and endoderm
development (Fig. 2B, AW1–3 and AB1–3). Similarly, WNT11
was induced in both AW and AB cultures over the 3-day time
course (Fig. 2C, AW1–3 and AB1–3), consistent with its role in
regulating gastrulation. Of note, the high levels of WNT11
expression coincided with the expression of endodermal markers
SOX17, HNF3, NODAL, and CRIPTO in both models.
AW-Driven hESC Differentiation Induces Rapid and Homogeneous
Hepatic Endoderm Differentiation. In addition to a role for Wnt3a
in facilitating endoderm differentiation, we also the studied
capability of those endodermal cell populations to form hepatic
A
E F G H
B C D
Fig. 1. Wnt3a and dipeptidyl peptidase IV (DPPIV) immunostaining in human T1 and T2 embryonic liver. Wnt3a expression was pronounced in areas near
developing portal structures (A) but absent from the parenchyma (B) in T1 liver. In contrast, Wnt3a expression was detected in portal and parenchymal regions
in T2 liver (C and D). DPPIV is a bile duct marker, and we it used as a positive control of bile duct localization. DPPIV expression was detected in both portal and
parenchymal regions in T2 (E and F) sections. Immunostaining controls (G and H) stained negative, thereby demonstrating specificity. Immunohistochemistry
images were captured using a Nikon TE300/U. (Scale bar, 100 M.)
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endoderm. Cells treated with AW or AB were transferred to
other types of media known to specify hepatic endoderm (23).
Cells primed with AW exhibited hepatocyte morphology by day
10 (Fig. 3A, AW H1 and AW H9), in contrast with cells
differentiated with AB, which required 14 days’ differentiation
before they developed characteristic hepatocyte morphology
(Fig. 3A, AB H1 and AB H9). In addition to the relative delay
in hepatocyte appearance, we also detected many areas of
overgrowth in AB cultures (Fig. 3A, AB H1 and AB H9). The
number of hESC-derived hepatocytes in culture was assessed
morphologically, by their polygonal shape and prominent nucle-
oli, and confirmed by albumin staining. The differentiation of H1
hESCs using AW yielded 90%  3% albumin-positive hepato-
cytes (Fig. 3B, AW H1) on day 17, compared with 72%  8% of
albumin-positive cells seen in response to AB (Fig. 3B, AB H1)
on day 17. We also tested an independent hESC line, H9, and
demonstrated that AW and AB treatment elicited similar
amounts of human hepatocyte differentiation (Fig. 3B, AW H9
and ABH9). Specificity of immunostaining was confirmed using
an IgG-negative control (Fig. 3B, IgG). Cells were maintained in
culture to day 18, and their gene expression was analyzed by
RT-PCR (Fig. 3C). Our results show that H1 or H9 cells
differentiated by either method expressed CYP7A1, seen in liver
but not yolk sac, and a repertoire of hepatocyte markers: ALB,
AFP, HNF4, TAT, TO, APOF, and CYP3A4.
AW-Driven hESC Differentiation Produces HLCs That Express a Wide
Variety of Hepatocyte-Specific Functions. In addition to marker
expression, we studied hESC-derived hepatocyte functionality.
hESC-derived AW and AB HLCs (AWHLCs and ABHLCs,
respectively) were matured using either L-15 (26) or Eagle’s
Minimal Essential Medium (MEME) in the presence or absence
of a mixture known to induce hepatocyte function in vitro (27).
After incubation, hepatocyte metabolism was measured by 2
assays, ureagenesis and gluconeogenesis. AWHLCs matured in
either L-15 or MEME plus lactate, pyrurate, octanoate, and
ammonium chloride (LPON) exhibited greater urea production
than their ABHLC counterparts (Fig. 4A). hESC-derived hepa-
tocytes from either protocol exhibited a similar pattern of
gluconeogenesis, which was enhanced in the presence of LPON
(Fig. 4B). Liver synthetic function was measured using ELISA.
In addition to  fetoprotein (AFP), other proteins included
fibrinogen, fibronectin, thyroxin-binding prealbumin (TBPA),
and haptoglobin. AWHLCs secreted greater amounts of AFP
(Fig. 4C), fibrinogen (Fig. 4D), and TBPA (Fig. 4E) than
ABHLCs. The production of fibronectin (Fig. 4F), haptoglobin,
and albumin (Fig. 4G) was similar in both treatment groups.
AW-Differentiated HLCs Engraft in Vivo and Are More Functional than
ABHLCs.A criticial ability of hESC-derived hepatocytes to engraft
into the spleen was examined in vivo using NODscid mice.
Fig. 2. Wnt signaling pathways play an important role in endoderm speci-
fication. (A) WNT3a is down-regulated in response to AW throughout differ-
entiation (AW1–3). WNT3a is dramatically up-regulated in response to AB
before down-regulation (AB1–3). (B) Levels ofWNT3are unchanged from days
1 to 3 in response to AW and AB (AW1–3 and AB1–3). (C) WNT11 is up-
regulated in response to both AW and AB, coinciding with a decrease in
WNT3a (AW1–3 and AB1–3). qPCR amplicons were measured using an ABI
Prism 7900. AW1–3, AW-treated cells on days 1, 2, or 3; AB1–3, AB-treated cells
on days 1, 2, or 3. (Scale bar, 100 M.)
Fig. 3. Wnt3a plus ActivinA promotes increased hepatocytic differentiation
of hESCs. (A) Cellular morphology at day 10 in AW- and day 14 in AB-
differentiated H1 and H9 hESC lines. Cells produced by AW show very little
overgrowth (OG) compared with cells produced by AB. (B) More efficient
generation of albumin-positive hepatocytes from hESCs using AW (90% H1
and87% H9) than AB (72% H1 and75% H9). IgG staining was used as a
negative control. Immunostaining was recorded using a Leica DMIRB. (Scale
bar, 100 M.) Results are presented as a mean of four fields of view  SE. (C)
Gene expression of in vitro-derived cells were examined using semiquantita-
tive PCR. ALB, albumin; AFP,  fetoprotein; HNF4, hepatocyte nuclear factor
4 ; TAT, tyrosine amino transferase; TO, tryptophan dioxygenase; APOF,
apolipoprotein F; 3A4, cytochrome p450 3A4; 7A1, cytochrome p450 7A1;
Actin, -actin; F, fetal liver cDNA; A, adult liver cDNA.
Hay et al. PNAS  August 26, 2008  vol. 105  no. 34  12303
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hESC-derived HLCs (106) were injected intrasplenically into
adult mice (aged 8–10 weeks). Three days after injection the
animals were killed, and the presence of hESC-derived hepato-
cytes was detected using human-specific CK18, CK19, human
FISH, and albumin staining. Clusters of AW-derived human
CK18- and CK19-positive HLCs were detected in the spleen of
recipient animals (Fig. 5A–C). Hepatocytes present in the spleen
also stained positive for humanDNA by FISH, which colocalized
with albumin staining, demonstrating hepatocellular function in
vivo (Fig. 5 D–F). In addition to AWHLCs, clusters of ABHLCs
exhibiting the above attributes were also detected in the spleen
of recipient animals (Fig. 5G–L). Human albumin production in
mouse serum was measured using ELISA. ELISA serum absor-
bance values for mice with AWHLCs engrafted were 7.5-fold
greater than those for control mice, whereas for ABHLCs values
were 3.3-fold greater than those of control mice. These results
indicate either that AWHLCs are a more functional cell popu-
lation or that a greater number of cells proliferated or engrafted
in vivo.
Wnt3a Treatment Facilitates Single-Cell Cloning of hESCs Capable of
HLC Differentiation and Function in Vitro. Because AWHLCs exhib-
ited a broader range of hepatic function than ABHLCs, AWHLCs
were used in p450metabolic studies. Cytochrome p450smetabolize
both exogenous and endogenous compounds, accounting for their
central importance in human health. hESC-derived HLCs dis-
played CYP1A2 (0.012  0.002 pmol/minmg protein) metabolic
activity that could be assayed in 12-well format (Fig. 6A). The ability
to move models of liver function, in particular p450 metabolism, to
a high-throughput format is attractive to drug toxicology testing
programs. In an attempt to provide high-throughput format mod-
els, we studied the ability of hESC to plate as small colonies that
could be seeded into 96-well plates. Wnt3a pretreatment of hESCs
(whESC) promoted hESCs self-renewal, and after passaging,
hESCs displayed looser and smaller colony structure than non-
treated hESCs. We reasoned that if hESCs could self-renew in
Fig. 4. AWHLCs display increased human liver function in vitro. (A) Urea
synthesis, J Urea (molh1gTP1), was measured from cells derived from both
AW and AB protocols. hESC-derived hepatocytes differentiated with AW
exhibited greater urea production than cells differentiated with AB. (B)
Gluconeogenesis was comparable in both treatment groups. Gluconeogene-
sis, [Glc] (umolh1gTP1), was greater in cells treated with LPON (L). (C–G)
Serum protein production was measured by ELISA on days 15, 16, and 17, and
units are quoted as g/24 h. AW-differentiated cells exhibited greater pro-
duction of AFP, fibrinogen, and TBPA than AB cells. *, P 0.01 by Student’s t
test. HLCs from both protocols exhibited similar levels of fibronectin, hapto-
globin, and albumin, (n  6). (H) Albumin protein production was measured
by ELISA on day 17, and units are quoted as g/24 hr.
A B
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Fig. 5. AW and AB HLCs engraft in the spleen and liver in vivo. (A and B)
Clusters of AW-derived hepatocytes expressing CK18 (A) and CK19 (B) in the
spleen. (C) IgG control. (D) Clusters of AW-derived hepatocytes detected by
FISH. (E) Human cells express albumin in the spleen. (F) FISH/immunostaining
overlay. (G andH) Clusters of AB-derived hepatocytes expressing (G) CK18 and
(H) CK19 in the spleen. (I) IgG controls. (J) Clusters of AW-derived hepatocytes
detected by FISH. (K) Human cells express albumin in the spleen. (L) FISH/
immunostaining overlay. (M) Transplanted AW and AB HLCs express albumin
in vivo as detected by ELISA. The results presented are a mean of four
animals SE. *, P 0.01 by Student’s t test. Phase images were recorded using
a Zeiss Axioplan fluorescent microscope. (Scale bar, 100M.) Immunostaining
was recorded using a Zeiss Axioplan fluorescent microscope.
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smaller colonies, they may also tolerate single-cell cloning. To test
our hypothesis we seeded 96-well plates with single whESCs and
grew them to confluence. Five whESC clones, selected from 50,
were expanded and passaged 10 times before hESC identity and
differentiation potential were assessed using FACS (Fig. 6B).
Clonally derived hESC expressed the correct repertoire of hESC
cell-surface markers (SSEA4, Tra1–60, and Tra1–81), expressed
Oct-4, and were capable of forming embryo bodies exhibiting cell
types from all three germ layers. In addition to hESC self-renewal
and pluripotentiality, we tested clonally derived lines’ ability to
differentiate toward hepatic endoderm. AW-driven hepatocyte
differentiation was carried out as before, and hepatic identity was
assessed by morphology, albumin expression, and CYP1A2 meta-
bolic activity (0.071  0.026 pmol/minmg protein) indicative of
scalable hepatic differentiation and high-throughput function in
vitro. The HLCs were compared with freshly isolated human
hepatocytes. Populations of HLCs derived in 12-well plates exhib-
ited CYP1A2 activity equivalent to 4% of that observed from adult
hepatocytes. In contrast, HLCs derived from clonal lines exhibited
CYP1A2 activity at 24% of adult hepatocytes, demonstrating
significantly improved drug metabolism.
Discussion
The results presented here demonstrate efficient and scalable
human HLC generation in vitro. The exposure of hESCs, in a
manner designed to mimic events in the developing embryo,
resulted in their homogeneous hepatocellular differentiation
and displayed increased hepatocellular function in vitro and in
vivo. Wnt treatment, in addition to promoting cellular function-
ality, also facilitated the high-throughput study of human liver
function in vitro.
The liver bud is formed from foregut endoderm during devel-
opment. The generation of this structure begins with establishment
of the PS and its derivative germ layers. Both Wnt and Activin
signaling pathways have been shown to play important roles in
mesoderm and endoderm specification (28–30). In addition,
Wnt3a’s expression in developing human liver made it a candidate
factor for directing efficient hESC hepatocyte differentiation. Our
second model, AB, was chosen for its ability to form relatively high
levels of hepatic endoderm, and we reasoned that this would serve
as an established comparative (31). Monolayers of hESCs were
differentiated using the two models producing HLCs that express
epithelial and biliary markers in vitro and in vivo, which mimics the
phenotype of oval/progenitor cell in vivo. hESCs treated with AW
promoted a more rapid transition through the PS than cells
differentiated with AB. Of note, the dramatic increase in WNT3a
and BRACHYURY at day 2 in AB cells could be responsible for the
late induction of endoderm markers SOX17 and HNF3. The
subsequent differentiation of DE to hepatic endoderm, using AW,
was more rapid and promoted hepatic function in vitro and in vivo.
In addition to its role in cellular differentiation, Wnt3a has also
been studied in hESC single-cell plating. In a previous studyWnt3a
promoted both cellular replating and differentiation and as a result
was consequently was less effective than hESC clonal passaging
(32). In contrast, our results demonstrate that Wnt3a treatment of
hESCs promoted their single-cell dissociation and self-renewal,
promoting undifferentiated hESC clonal passaging.
There are a number of signaling pathways involved in the
complex cascade of events that lead to DE formation. In both our
models, cells initially expressed genes indicative of PS formation
and went on to express endodermal genes in a manner akin to
human development. The induction of Brachyury by Wnt3a (24)
and Sox17 by Nodal (33) are well documented and consistent with
our observations. In addition, both Brachyury and Sox17 are known
to be essential components in drivingWNT11 expression (34) and,
in agreement with previous experiments, we demonstrate that
increasedWNT11 expression is paralleled by a decrease inWNT3A
andBRACHYURY expression (35). In effect,Wnt11 could be acting
as a molecular switch responsible for the commitment of differen-
tiating cells to DE. The mesendodermal-to-endodermal transition
requires a fundamental change in cellular gene expression pro-
grams. Although we observe down-regulation of BRACHYURY
andWNT3A,WNT3 expression was still detectable, indicating that
-Catenin signaling, responsible for Cripto induction (36), is still
active in differentiating cells. It may be the case that Wnt11-
mediated shutdown of Wnt3a-driven -Catenin/TCF signaling
dampens downmesoderm formation and thatWnt3-driven -Cate-
nin signaling is respecified to an endodermal program of gene
expression.With this inmind, it is interesting to note that Sox17 and
-catenin heterodimers have been shown to cooperate in the
regulation of endodermal gene expression (37) and therefore may
represent one of the Wnt11 effector complexes in endoderm
specification.
In conclusion, we demonstrate the efficient generation of hESC-
derived HLCs that differentiate through appropriate in vivo inter-
mediates. This has led to the generation of a scalable liver differ-
entiation model that bypasses the problems associated with
sourcing and culturing primary human hepatocytes. Additionally,
we predict that our high-throughput technology will not only be
Fig. 6. Wnt treatment of hESCs promotes p450 function and high-
throughput screening in vitro. (A) hESCs (ES) and AWHLCs (AW) were incu-
bated with substrate for 24 h. After incubation cellular supernatants were
harvested, and metabolite production was determined by mass spectrometry
(Thermo Electron), normalized to protein levels, and expressed as pmol/
minmg protein. AWHLC displayed greater CYP1A2 metabolism than ES cells
(n 3). (B) hESCs were treated with Wnt3a, single-cell cloned in 96-well plates
and expanded in vitro. After 10 passages, ES cell-surface markers were ana-
lyzed by FACS. Single-cell cloned hESCs retained expression of hESC markers
SSEA4, Tra1–60, and Tra1–81 and did not express SSEA1, a marker of hESC
differentiation. (C) Clonally plated hESCs could be differentiated to HLCs in
96-well plates. Cells that exhibited HLC morphology also expressed albumin in
vitro. (D) AW-treated hESCs differentiated to HLCs exhibited CYP1A2 meta-
bolic activity, which could be assayed in 96-well plate format in vitro (n 10).
*, P  0.01 by Student’s t test.
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important in the prediction of hepatotoxicity but will be extremely
useful in the generation of other developmental testing models.
Materials and Methods
Cell Culture and Differentiation. hESCs (H1 and H9) were cultured and prop-
agated as described (23, 38). Differentiation was initiated at 60–70% conflu-
ence, by replacing mouse embryomic fibroblast conditioned medium (MEF-
CM) with differentiation medium (RPMI1640 containing 1 B27 (both from
Invitrogen), 1 mM sodium butyrate (Sigma), and 100 ng/ml ActivinA (Pepro-
tech) or 50 ng/ml Wnt3a (R&D Systems) and 100 ng/ml ActivinA. After 72 h
(changing medium every day), differentiating cells were cultured in subse-
quent differentiation media as described in ref. 31.
RNA Isolation and RT-PCR. Total RNA was harvested from cells and underwent
RT-PCR as described (23, 38). Total RNA from mouse tissue was isolated using
RNeasy Plus mini kit (Qiagen 74134) as per the manufacturer’s instructions.
cDNA was generated using TaqMan reverse transcription reagent (Applied
Biosystems N8080234). Quantitative PCR was carried out as described (39) and
measured on an ABI Prism 7900 (Applied Biosystems. Optimized primer con-
ditions for PCRs are shown in Tables S1 and S2.
Immunofluoresence and Immunohistochemistry. Monolayer cultures were
fixed and stained as described (23). Human and mouse tissues were embedded
in paraffin and 3-m serial sections were cut. Sections were microwaved in the
following heat retrieval methods: 10 mM Tris, DAKO target retrieval high pH
(S3306), or 10 mM citrate buffer, incubated in 3% H2O2 for 5 min. Optimized
concentrations of primary and secondary antibodies are shown in Table S3.
Measurement of Hepatocyte Export Proteins. Cells were cultured in 6-well plates
in 1 ml of L-15, and after 24-h supernatants were collected for export protein
assay. The hepatic export proteins were measured as described (27, 40, 41).
Measurement of Hepatocyte Metabolism. Hepatocyte metabolism was mea-
sured in the context of gluconeogenesis and ureagenesis as described (27).
CYP1A2 activity was measured in 1  105 HLCs or freshly isolated human
hepatocytes (Johnson & Johnson) using 2 M 7-ethoxyresorufin in culture
medium for 24 h at 37°C. Liberated resorufin was fluorometrically analyzed
(excitation, 550 nm; emission, 585 nm) in a Safire spectrophotometer (Tecan)
and reported as specific activity (pmol/minmg protein)  SEM.
Animals. Adult NOD.CB17-Prkdcscid/J mice were purchased from the Jackson
Laboratory and housed in individual ventilated cages. Experimental protocols
were carried out in accordance with permits and guidelines issued by the
University of Edinburgh Ethical Review Committee and the United Kingdom
Home Office (Project Licence 60/2914). Cells were differentiated in the AW or
the AB protocol for 10 or 14 days, respectively. Cells were harvested using
trypsin-EDTA and filtered through a 100-mM filter. NODscid mice (aged 8–10
weeks) were injected intrasplenically with 1  106 cells after laparotomy.
FISH. Formalin-fixed, paraffin-embedded sections were dewaxed and rehy-
drated. The sections were then microwaved in 10 mM citrate buffer for 20 min
and denatured in 70% formamide in 2 SSC for 3 min, dehydrated through
90–100% EtOH, and air dried digoxygenine (DIG)-labeled human genomic DNA
(150 ng) was hybridized overnight at 37°C. Slides were washed 4 3 min in 2
SSC at 45°C, followed by 43 min in 0.1SSC at 60°C. Slides were then incubated
in FITC-labeled sheep anti-DIG for 30 min, washed 3  2 min in 4 SSC/0.1%
Tween, and then incubated in FITC-labeled antisheep antibody for 30 min,
washed 3 2 min in 4 SSC/0.1% Tween, mounted in Vectorshield DAPI (Vector
Laboratories), and visualized using a Zeiss Axioplan fluorescent microscope.
Flow Cytometry. Optimized concentrations for flow cytometry were used as
described (42).
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